Lazard Research & Insights


Back Clear all Clear

Healthcare leaders are entering 2026 with cautious optimism and a sharper focus on execution — even as the imperative to deploy capital remains intense.


September 22, 2025

Lazard Global Biopharmaceutical Leaders Study 2025

Biopharmaceutical and biotech investors ended the summer of 2025 amid heightened uncertainty and significant financial market pressures.

April 07, 2025

Lazard Healthcare Services Leaders Study 2025

Lazard Healthcare Services Leaders Study 2025